Can morbidity and mortality of matched allogeneic marrow grafts be reduced?
Biggs
J C
JC
Department of Haematology, St Vincent's Hospital, Sydney, Australia.
Atkinson
K
K
Dodds
A J
AJ
Downs
K
K
D000206:Actuarial Analysis; D016026:Bone Marrow Transplantation; D003556:Cystitis / Q000517:prevention & control; D006504:Hepatic Veno-Occlusive Disease / Q000401:mortality / Q000517:prevention & control; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D011183:Postoperative Complications / Q000401:mortality / Q000517:prevention & control*; D011300:Preoperative Care; D011658:Pulmonary Fibrosis / Q000401:mortality / Q000517:prevention & control; D014184:Transplantation, Homologous / Q000009:adverse effects
D007166:Immunosuppressive Agents